Mediwound Ltd
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -0.8% | -6.1% | -8.1% | +30.4% | -1.7% | -6.1% | -2.9% | +40.9% | -8.7% | -7.3% | -10.1% | |
| – | -6.7% | -11.1% | -15.6% | +44.4% | -3.2% | -9.9% | -8.4% | +61.4% | -13.8% | -13.0% | -17.7% | |
| – | +27.9% | +199.7% | -89.3% | +1,102.2% | -79.9% | +318.0% | -97.2% | +5,479.8% | -91.9% | +830.3% | -90.3% | |
| – | -8.7% | -14.4% | -17.9% | +56.0% | -79.9% | +318.0% | -15.2% | +82.2% | -10.1% | -16.0% | -20.8% | |
| – | +8.5% | +20.3% | -8.1% | +8.5% | +10.3% | -11.6% | +31.4% | -11.2% | -60.7% | +15.9% | +27.1% | |
| – | -22.2% | +16.3% | -3.1% | -5.9% | -10.9% | +33.0% | +7.3% | +14.6% | -7.1% | +16.6% | -13.7% | |
| – | -9.3% | -9.7% | -11.4% | -12.1% | -14.7% | -16.2% | -20.5% | -24.2% | -34.0% | -48.5% | – | |
| – | +2.6% | +12.4% | -19.8% | +28.9% | +4.6% | -10.9% | -0.3% | +17.7% | -3.7% | -9.5% | -6.0% | |
| – | +28.3% | +106.3% | +1.2% | +13.1% | +3.8% | -17.7% | +33.1% | -9.7% | -2.1% | -15.8% | -14.3% | |
| – | – | +0.0% | -2.9% | – | – | – | – | +28.6% | -41.1% | +49.1% | +0.3% | |
| – | +14.8% | +0.5% | -35.4% | +14.1% | +30.8% | +21.9% | +17.8% | +44.7% | -57.6% | +105.4% | +2.9% | |
| – | -4.4% | -26.6% | -23.0% | +91.6% | -9.0% | +0.4% | -35.7% | +149.3% | -13.0% | -5.1% | -14.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.2% | +0.5% | +13.3% | +2.7% | +0.1% | +0.3% | +1.7% | +16.4% | +0.4% | +0.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.